UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000000535 |
|---|---|
| Receipt number | R000000648 |
| Scientific Title | Prospective study of wide excision and endocrine therapy WithOut RadioTHerapy (WORTH) for node-negative estrogen receptor positive early breast cancer with histologically negative margins (WORTH trial)(No.3) |
| Date of disclosure of the study information | 2006/12/10 |
| Last modified on | 2019/12/16 20:33:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2006/12/02 15:53:29 | ||
| 2 | Update | 2007/01/06 19:31:45 | Recruitment status |
|
| 3 | Update | 2007/01/06 19:32:32 | Key exclusion criteria |
|
| 4 | Update | 2007/12/09 15:40:26 | ||
| 5 | Update | 2008/06/12 20:02:59 | Tel1 Email1 |
|
| 6 | Update | 2009/06/07 19:48:12 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Address Address TEL Organization Organization |
|
| 7 | Update | 2009/12/21 17:16:50 | Recruitment status |
|
| 8 | Update | 2010/12/02 12:30:50 | Email1 |
|
| 9 | Update | 2011/12/03 19:25:34 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 10 | Update | 2013/06/02 09:48:04 | Recruitment status Last follow-up date |
|
| 11 | Update | 2013/12/02 09:28:36 | Email |
|
| 12 | Update | 2016/06/02 09:31:35 | Name of primary person or sponsor Organization Category of Funding Organization |
|
| 13 | Update | 2019/12/16 20:33:01 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
